<DOC>
	<DOCNO>NCT01731431</DOCNO>
	<brief_summary>This clinical trial aim test whether glibenclamide non-inferior insulin treatment gestational diabetes .</brief_summary>
	<brief_title>Multicenter Randomized Trial Non-inferiority Between Glyburide Insulin Treatment Gestational Diabetes</brief_title>
	<detailed_description>In patient gestational diabetes , therapeutic treatment diet , blood glucose monitoring , necessary , treatment insulin associate reduced neonatal complication . Although effectiveness insulin proven , therapy many drawback , especially term implementation monitor woman . An alternative use oral antidiabetic agent like glibenclamide . Assumption : Glibenclamide non-inferior insulin treatment gestational diabetes . Main objective : To test oral Glibenclamide non-inferior subcutaneous insulin occurrence perinatal complication management pregnant woman develop gestational diabetes require treatment dietary . Secondary Objective : To test noninferiority two treatment maternal glycemic control maternal complication . Sample size : With 80 % power significance level 5 % , 450 subject per group require show treatment glibenclamide consider inferior treatment insulin frequency outcome composite exceed 25 % glibenclamide , whereas 18 % insulin ( calculated non-inferiority margin 7 % consider 20 % patient treat glyburide Insulin change half patient accept randomization ) . Progress study : Inclusion woman 24 34 week . Randomization Insulin Glibenclamide failure 10 day dietary treatment well do . Failure define least 2 abnormal value glycemia : fasting glucose ≥ 0.95 g / l and/or postprandial 2h ≥ 1.20 g / l. Women receive either insulin accord usual protocol Glibenclamide initial dose 2.5 mg / daily morning breakfast . So long glycemic target reach dos gradually increase stepwise every 4 day day 21 ( 20mg/j ) . Patients reach glycemic target high dose change treatment insulin day 21 . Routine monitoring pregnant woman gestational diabetes , week delivery Number clinical site : 15 Perspective : Use Glibenclamide first line treatment gestational diabetes require drug treatment .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>gestational diabetes diagnose 24 34 week accord international criterion . Multiple Pregnancy Chronic Hypertension Preeclampsia Renal impairment Hepatic insufficiency Long time corticosteroid treatment Allergy sulfa drug Preexisting diabetes pregnancy Abnormal result screen test gestational diabetes 24SA Fasting glucose ≥ 1.26 g / l initial diagnosis diabetes The need drug treatment contraindicate recommend take Glibenclamide Poor understand French Lack Social Insurance</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Gestational Diabetes ,</keyword>
	<keyword>Insulin ,</keyword>
	<keyword>Glyburide ,</keyword>
	<keyword>Glycemia</keyword>
</DOC>